iifl-logo-icon 1

Thyrocare Technologies Ltd Share Price

640.5
(0.65%)
Jul 22, 2024|10:09:53 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open634.1
  • Day's High646.45
  • 52 Wk High722.65
  • Prev. Close636.35
  • Day's Low630.55
  • 52 Wk Low506.8
  • Turnover (lac)86.85
  • P/E47.38
  • Face Value10
  • Book Value108.26
  • EPS13.43
  • Mkt. Cap (Cr.)3,391.62
  • Div. Yield2.83
No Records Found

Thyrocare Technologies Ltd KEY RATIOS

Sector

Healthcare

Open

634.1

Prev. Close

636.35

Turnover(Lac.)

86.85

Day's High

646.45

Day's Low

630.55

52 Week's High

722.65

52 Week's Low

506.8

Book Value

108.26

Face Value

10

Mkt Cap (₹ Cr.)

3,391.62

P/E

47.38

EPS

13.43

Divi. Yield

2.83

Thyrocare Technologies Ltd Corporate Action

18 Jul 2023

12:00 AM

AGM

Announcement Date: 18 Jul, 2023

arrow

7 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Thyrocare Technologies Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Thyrocare Technologies Ltd SHAREHOLDING SNAPSHOT

22 Jul, 2024|10:31 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 71.11%

Foreign: 0.00%

Indian: 71.11%

Non-Promoter- 17.38%

Institutions: 17.38%

Non-Institutions: 11.49%

Custodian: 0.00%

Share Price

Thyrocare Technologies Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

71.85

52.9

52.87

52.84

Preference Capital

0

0

0

0

Reserves

449.19

467.8

392.59

325.39

Net Worth

521.04

520.7

445.46

378.23

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

561.53

474.27

400

331.79

yoy growth (%)

18.39

18.56

20.55

11.51

Raw materials

-165.23

-160.55

-112.34

-90.84

As % of sales

29.42

33.85

28.08

27.37

Employee costs

-58.82

-56.79

-45.75

-32.48

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

207.38

161.28

156.33

150.15

Depreciation

-28.47

-21.08

-19.54

-12.08

Tax paid

-55.33

-41.51

-32.68

-51.92

Working capital

67.33

22.23

-22.08

-14.1

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

18.39

18.56

20.55

11.51

Op profit growth

35.19

2.41

19.92

21.17

EBIT growth

29.52

2.72

4.7

31.56

Net profit growth

26.95

50.99

-17.4

105.78

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

571.88

526.67

588.86

494.62

433.2

Excise Duty

0

0

0

0

0

Net Sales

571.88

526.67

588.86

494.62

433.2

Other Operating Income

0

0

0

0

0

Other Income

9.76

9.6

29.25

12.43

8.24

Thyrocare Technologies Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

6,381.95

90.8591,806.5238.80.091,894.6536.28

Max Healthcare Institute Ltd

MAXHEALTH

920.45

130.1389,420.8241.770.16610.1179.02

Fortis Healthcare Ltd

FORTIS

481.4

293.1736,298.3968.330.21307.48120.36

Global Health Ltd

MEDANTA

1,204.3

89.6132,288.0192.240578.65106.09

Narayana Hrudayalaya Ltd

NH

1,242.45

59.825,381.61158.090.32846.3190.04

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Thyrocare Technologies Ltd

Management

Register Office

Registrar Office

Independent Director

GOPAL SHIVRAM HEGDE

Independent Director

Neetin Shivajirao Desai

Independent Director

VISHWAS MADHAV KULKARNI

Company Sec. & Compli. Officer

RAMJEE DORAI

Independent Director

Indumati Gopinathan

Non-Exec & Non-Independent Dir

Dhaval Shah

Non-Exec & Non-Independent Dir

Dharmil Sheth

Chairman & MD & CEO

Rahul Guha

Non-Exec & Non-Independent Dir

Hardik Dedhia

Independent Director

Prapti Ishwar Gilada

Independent Director

Harshil Jiten Vora

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Thyrocare Technologies Limited was incorporated in the year January 28, 2000. The Company is one of the leading pan-India diagnostic chains that conduct an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases. As of 31 March 2022, the Company offered 636 distinct tests and 90 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases. Their 34 profiles are administered under its reputed Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs). The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.Nueclear Healthcare Limited (NHL), the wholly owned subsidiary of Thyrocare Technologies, is engaged in PET-CT Scan imaging diagnostic business. NHL currently has 10 active operating PET-CT scanners in 8 imaging centers: two in Navi Mumbai, two in New Delhi, one each in Hyderabad, Central Mumbai, Western Mumbai, Baroda, Nashik and Bangalore. NHL also owns
Read More

Company FAQs

What is the Thyrocare Technologies Ltd share price today?

Down Arrow

The Thyrocare Technologies Ltd shares price on N/A is Rs.₹642.15 today.

What is the Market Cap of Thyrocare Technologies Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Thyrocare Technologies Ltd is ₹3400.36 Cr. as of 22 Jul ‘24

What is the PE and PB ratio of Thyrocare Technologies Ltd?

Down Arrow

The PE and PB ratios of Thyrocare Technologies Ltd is 47.38 and 6.56 as of 22 Jul ‘24

What is the 52 Week High and Low of Thyrocare Technologies Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Thyrocare Technologies Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Thyrocare Technologies Ltd is ₹511 and ₹722 as of 22 Jul ‘24

What is the CAGR of Thyrocare Technologies Ltd?

Down Arrow

Thyrocare Technologies Ltd's CAGR for 5 Years at 7.54%, 3 Years at -21.53%, 1 Year at 7.91%, 6 Month at 1.55%, 3 Month at 0.23% and 1 Month at -0.25%.

What is the shareholding pattern of Thyrocare Technologies Ltd?

Down Arrow

The shareholding pattern of Thyrocare Technologies Ltd is as follows:
Promoters - 71.11 %
Institutions - 17.39 %
Public - 11.50 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.